Recently, reports have shown that cerebrospinal fluid (CSF) levels of Aβ1–42, total tau (T-tau), and phosphorylated tau (ptau) were altered in AD patients and in patients with mild cognitive impairment (MCI) with higher risks to convert to AD (15). Here, MAPT is linked to Alzheimer disease.